Newsletter

Ujjwal Maheshwari

Ujjwal Maheshwari is a Sydney-based financial writer at Stocks Down Under, where he has covered ASX and forex markets for over three years. He specialises in breaking down complex market developments into clear, accessible analysis for everyday investors.

Bachelor of Commerce (Finance), University of New South Wales (UNSW)

730 articles published

Cryptocurrencies

How Institutions Are Changing Crypto Investing

Cryptocurrency is no longer a niche idea. What initially began as an experiment has become a significant asset class and has a large number of connections with conventional finance. To meet investor demand for insight into how blockchain-based assets can be used into diversified portfolios, the current environment provides the opportunity and clarity today, as…

ByUjjwal MaheshwariJanuary 15, 20260Comments

Lithium Stocks

PLS Group (ASX:PLS) Surges to 52-Week High After 167% Lithium Rally: Buy or Wait?

PLS Group Soars as Lithium Recovery Gains Momentum PLS Group (ASX: PLS), formerly known as Pilbara Minerals, hit a fresh 52-week high of A$4.94 this week as lithium prices surged to their best levels since late 2023. The rally started after China said it would remove tax rebates for battery exports. Since mid-2025, lithium prices…

ByUjjwal MaheshwariJanuary 15, 20260Comments

Uranium Stocks

Deep Yellow (ASX:DYL) Fast-Tracks New CEO Ahead of Tumas FID : Should You Buy Now?

Deep Yellow Brings CEO Forward as Tumas FID Nears Deep Yellow (ASX:DYL) shares are trading at A$2.03, up more than 70% over the past year. The uranium developer just announced it's bringing forward its new CEO's start date by three months. Greg Field will now begin on February 2, 2026, instead of the originally planned…

ByUjjwal MaheshwariJanuary 15, 20260Comments

Copper Stocks

Norfolk Metals (ASX:NFL) Confirms High-Grade Copper in Chile: Is This A$8M Explorer a Buy?

Norfolk Metals Hits High-Grade Copper in Chile Norfolk Metals (ASX: NFL) is making waves after releasing impressive copper results from its first drilling campaign at the Carmen Copper Project in Chile. The standout hit was 32 metres grading 1.3% copper from just 97 metres below the surface, with mineralisation still open at depth. The company…

ByUjjwal MaheshwariJanuary 15, 20260Comments

Biotech Stocks

Neuren Pharmaceuticals (ASX:NEU) Surges 6% on US$700m DAYBUE Target: Time to Buy?

DAYBUE royalties could climb fast if US targets land Neuren Pharmaceuticals (ASX: NEU) jumped 6% on Wednesday after its US partner, Acadia Pharmaceuticals, shared big news at the J.P. Morgan Healthcare Conference. Acadia now expects DAYBUE sales to hit US$700 million by 2028, sending Neuren shares to around A$20.47. The stock has climbed more than…

ByUjjwal MaheshwariJanuary 15, 20260Comments

Mining Stocks

European Lithium (ASX: EUR) Surges 50% as Greenland Pilot Plant Kicks Off: Is It a Buying Opportunity?

European Lithium surges on Greenland Tanbreez milestones European Lithium (ASX: EUR) has climbed roughly 50% from its lows, trading around A$0.26. The catalyst? Big progress at Critical Metals Corp (NASDAQ: CRML), where European Lithium holds a huge stake. Pilot plant construction started on January 7, 2026, and the company just ordered a US$1 million mobile…

ByUjjwal MaheshwariJanuary 14, 20260Comments

Biotech Stocks

NeuroScientific (ASX:NSB) Reports 75% Response Rate in Crohn’s Trial: Is This Stem Cell Stock a Buy?

NeuroScientific jumps on early Crohn’s stem cell results NeuroScientific Biopharmaceuticals (ASX: NSB) surged 43% on Tuesday after announcing promising early results from its stem cell program. Three out of four patients achieved a clinical response in a Special Access Program for fistulising Crohn's disease. The company's StemSmart therapy showed a 75% success rate in treating one…

ByUjjwal MaheshwariJanuary 14, 20260Comments

Rare Earths Stocks

Lynas (ASX:LYC) CEO Amanda Lacaze Steps Down After 12 Years: Buy the Dip or Take Profits?

Lynas CEO Amanda Lacaze steps down after 12 years Lynas Rare Earths (ASX: LYC) shares are in focus after the company announced that CEO Amanda Lacaze will retire after 12 years in the role. Shares initially jumped 3% on Tuesday before settling up around 2.4% at A$15.14 as investors weighed what this means for the…

ByUjjwal MaheshwariJanuary 14, 20260Comments

Healthcare Stocks

Singular Health (ASX:SHG) Gains FDA Clearance for Cloud Imaging Platform: Is This MedTech a Buy Now?

Singular Health secures FDA clearance for US rollout Singular Health Group (ASX: SHG) grabbed investor attention on Tuesday after the company announced FDA 510(k) clearance for its 3DICOM MD Cloud platform. Shares surged as high as A$0.30 in early trade, representing a 15% intraday gain, before profit-taking pulled the stock back to close at A$0.26.…

ByUjjwal MaheshwariJanuary 14, 20260Comments

Mining Stocks

iTech Minerals (ASX:ITM) Surges 33% on Antimony Drill Results: Is It a Buy Now?

iTech Minerals Surges on High-Grade Antimony Drill Results iTech Minerals (ASX: ITM) surged 33 per cent on Monday to A$0.064 after the company released drill results that confirmed gold and antimony mineralisation at its Reynolds Range Project in the Northern Territory. The stock had been languishing near all-time lows, so this move suggests investors are…

ByUjjwal MaheshwariJanuary 13, 20260Comments

the Kick-ass Multipurpose WordPress Theme

Ujjwal Maheshwari

How Institutions Are Changing Crypto Investing

PLS Group (ASX:PLS) Surges to 52-Week High After 167% Lithium Rally: Buy or Wait?

Deep Yellow (ASX:DYL) Fast-Tracks New CEO Ahead of Tumas FID : Should You Buy Now?

Norfolk Metals (ASX:NFL) Confirms High-Grade Copper in Chile: Is This A$8M Explorer a Buy?

Neuren Pharmaceuticals (ASX:NEU) Surges 6% on US$700m DAYBUE Target: Time to Buy?

European Lithium (ASX: EUR) Surges 50% as Greenland Pilot Plant Kicks Off: Is It a Buying Opportunity?

NeuroScientific (ASX:NSB) Reports 75% Response Rate in Crohn’s Trial: Is This Stem Cell Stock a Buy?

Lynas (ASX:LYC) CEO Amanda Lacaze Steps Down After 12 Years: Buy the Dip or Take Profits?

Singular Health (ASX:SHG) Gains FDA Clearance for Cloud Imaging Platform: Is This MedTech a Buy Now?

iTech Minerals (ASX:ITM) Surges 33% on Antimony Drill Results: Is It a Buy Now?

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Ujjwal Maheshwari

Stocks in Spotlight

Add Your Heading Text Here